Evidence map›Paper›PMID 29713545›Full record

ReviewArab journal of urology2018

Systematic review of hormone replacement therapy in the infertile man.

Amr El Meliegy, Ahmad Motawi, Mohamed Ahmed Abd El Salam

Open access · diamondAbstract readReview
In one paragraph

Review in Arab journal of urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Testicular cancer survivorship: Long-term toxicity and management.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Review
  9. Article
  10. Male factor infertility: Initial workup and diagnosis in primary care.Canadian family physician Medecin de famille canadien · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Low Testosterone in Adolescents & Young Adults.Frontiers in endocrinology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amr El MeliegyDepartment of Andrology, Sexology and STDs, Faculty of Medicine, Cairo University, Egypt and Department of Andrology, Dr. Soliman Fakeeh Hospital, Jeddah, KSA.
Ahmad MotawiDepartment of Andrology, Sexual Medicine and Sexually Transmitted Diseases, Faculty of Medicine, Cairo University, Egypt.
Mohamed Ahmed Abd El SalamDepartment of Andrology, Sexual Medicine and Sexually Transmitted Diseases, Faculty of Medicine, Cairo University, Egypt.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo highlight alternative treatment options other than exogenous testosterone administration for hypogonadal men with concomitant infertility or who wish to preserve their fertility potential, as testosterone replacement therapy (TRT) inhibits spermatogenesis, representing a problem for hypogonadal men of reproductive age. MATERIALS AND

methodsWe performed a comprehensive literature review for the years 1978-2017 via PubMed. Also abstracts from major urological/surgical conferences were reviewed. Review was consistent with the Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA) criteria. We used Medical Subject Heading terms for the search including 'testosterone replacement therapy' or 'TRT' and 'male infertility'.

resultsIn all, 91 manuscripts were screened and the final number used for the review was 56. All studies included were performed in adults, were written in English and had an abstract available.

conclusionsExogenous testosterone inhibits spermatogenesis. Hypogonadal men wanting to preserve their fertility and at the same time benefiting from TRT effects can be prescribed selective oestrogen receptor modulators or testosterone plus low-dose human chorionic gonadotrophin (hCG). Patients treated for infertility with hypogonadotrophic hypogonadism can be prescribed hCG alone at first followed by or in combination from the start with follicle-stimulating hormone preparations.

Indexed as

CC, clomiphene citrateE2, oestradiolGonadotrophinshCG, human chorionic gonadotrophinhMG, human menopausal gonadotrophinHPG, hypothalamic–pituitary–gonadalHypogonadismInfertilityPRISMA, Preferred Reporting Items for Systemic Reviews and Meta-AnalysesSERM, selective oestrogen receptor modulatorSHBG, sex hormone-binding globulinSystematic reviewTestosterone therapyTRT, testosterone replacement therapy

Identifiers

PMID29713545
PMCPMC5922183
OpenAlexW2777258080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.